Antibody response after a single dose of an AS03-adjuvanted split-virion influenza A (H1N1) vaccine in heart transplant recipients.
Related Research units
Abstract
Influenza A (H1N1) has emerged as a considerable threat for recipients of organ transplants. Vaccination against the novel influenza A (H1N1) virus has generally been advocated. There is limited experience with AS03-adjuvanted A/H1N1 pandemic influenza vaccines in immunosuppressed patients.
Bibliographical data
| Original language | English |
|---|---|
| Article number | 9 |
| ISSN | 0041-1337 |
| Publication status | Published - 2011 |
| pubmed | 21358365 |
|---|
